ArticleComputers in biology and medicine2022

Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.

Mohammed Baqur S Al-Shuhaib et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.